Award recordCONTRACT

TRAVERE THERAPEUTICS, INC.

PIID 36C24718K0013· VHA· 247-NETWORK CONTRACT OFFICE 7 (36C247)· 6505 · DRUGS AND BIOLOGICALS· FY2018· $87,515 net obligations· UEI JUBZMHK84S36· CA

Description

EXPRESS REPORT: FOR PHARMACY ORDERING OFFICER ORDERS FOR TIOPRONIN FOR FY18

First action · last action
2017-11-13 · 2017-11-13
Transactions
1
First transaction's obligation
$87,515
Base + all options value (sum of deltas)
$87,515
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA797P16A0018
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 1 transaction

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$87,515$0Base award · 2017-11-13 · this action $87,515 · running total $87,515
  • Base2017-11-13+$87,515= $87,515
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2017-11-13+$87,515$87,515EXPRESS REPORT: FOR PHARMACY ORDERING OFFICER ORDERS FOR TIOPRONIN FOR FY18

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI JUBZMHK84S36)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0794245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$15,867FY2026
36C24526N0779245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$33,372FY2026
36C24526N0725245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$15,867FY2026
36C24526N0675245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$15,867FY2026
36C24526N0571245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$33,372FY2026
36C24526N0554245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,667FY2026

Other recipients under 6505 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24726P0690SINA DRUG LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$188,463FY2026
36C24726N0211BOSTON SCIENTIFIC CORP247-NETWORK CONTRACT OFFICE 7 (36C247)$248,982FY2026
36C24726F0100AMICUS THERAPEUTICS US, LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$228,396FY2026
36C24726F0053EXELAN PHARMACEUTICALS INC247-NETWORK CONTRACT OFFICE 7 (36C247)$4,765,853FY2026
36C24726F0043AMICUS THERAPEUTICS US, LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$109,456FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24718K0013_3600_VA797P16A0018_3600 · retrieved 2026-09-26.